Drinkable supplement for hair loss in women on weight-loss drugs
Part of Skin clinical trials.
This trial tests if a special drinkable supplement can help prevent or reduce hair loss in women who are taking a GLP-1 or GIP receptor agonist (a type of weight-loss or diabetes medication). The study looks for women who have just started this medication or have been on it for less than 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman over 35 years old.
- You have been taking a GLP-1 or GIP agonist (like Ozempic, Wegovy, Mounjaro) for less than 3 months, or you are about to start.
- You have no known allergies to any ingredients in the study supplement.
- You do not have certain scalp conditions (like scarring alopecia, psoriasis, or severe dandruff).
- Your hair loss is not caused by an underlying medical condition (like thyroid disease, anemia, or lupus).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a daily drinkable supplement can help women with hair loss (telogen effluvium) that has lasted more than 3 months. It also checks how the supplement affects the gut bacteria and the scalp, possibly improving hair growth.
This study tests a new scalp product called DA-001 to see if it reduces hair shedding and helps hair grow back in people with telogen effluvium. It's a clinical trial that compares the treatment to a placebo (a product without the active ingredient) to find out if it works.
This study looks at how well a daily pill (oral minoxidil) works for mild female pattern hair loss, either by itself or combined with a drinkable supplement. It aims to see which approach improves hair growth and reduces shedding, and how it affects women's feelings about hair loss.
This study tests a dietary supplement to help women who are experiencing hair shedding (telogen effluvium) after using GLP-1 medications like semaglutide or tirzepatide for weight loss. It aims to see if the supplement can reduce hair loss and improve hair health.
This trial tests whether a combination of a dietary supplement and a topical serum can help women with thinning hair grow thicker, fuller hair. It's designed for women who have noticed mild to moderate hair thinning and want a non-invasive approach.
This trial tests a dietary supplement designed to reduce occasional hair shedding caused by stress, poor diet, pollution, or seasonal changes. If you've noticed more hair falling out than usual over the last few months, this study will see if the supplement helps improve your hair condition over 90 days.
Hear when a new Telogen Effluvium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.